Skip to main content
. 2021 Sep 8;157(10):1236–1237. doi: 10.1001/jamadermatol.2021.3341

Table 1. Comparison of Patient- and Clinician-Reported Outcome Measure Scores Assessing Disease Severity Among Patients With Psoriasis.

DLQI score for disease severity No. of patients (%) (N = 1733)
PASI score for disease severity BSA for disease severity
Mild (<3) Moderate (3-9) Severe (≥10) Mild (<3%) Moderate (3%-10%) Severe (>11%)
Mild (<6) (n = 1201) 621 (35.8) 461 (26.6) 119 (6.9) 700 (40.4) 353 (20.4) 148 (8.5)
Moderate (6-10) (n = 293) 73 (4.2) 149 (8.6) 71 (4.1) 79 (4.6) 135 (7.8) 79 (4.6)
Severe (>10) (n = 239) 39 (2.3) 120 (6.9) 80 (4.6) 51 (2.9) 104 (6.0) 84 (4.9)

Abbreviations: BSA, body surface area; DLQI, Dermatology Life Quality Index; PASI, Psoriasis Area Severity Index.